These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17016058)

  • 1. Mechanisms of aspirin-sensitive respiratory disease--a two-compartment model.
    Farooque S; Lee T
    Int Arch Allergy Immunol; 2007; 142(1):59-63. PubMed ID: 17016058
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Too many COX (cyclo-oxygenase) spoil the broth: aspirin-sensitive asthma and 5-lypoxygenase.
    Mitchell JA; Belvisi MG
    Thorax; 1997 Nov; 52(11):933-5. PubMed ID: 9487337
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.
    Passero M; Chowdhry S
    Chest; 2003 Jun; 123(6):2155-6; author reply 2156. PubMed ID: 12796206
    [No Abstract]   [Full Text] [Related]  

  • 5. COX-1 sparing drugs in aspirin-sensitive asthma.
    Picado C; Valero A
    Clin Exp Allergy; 2001 Feb; 31(2):179-81. PubMed ID: 11251618
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of COX-2 inhibition for aspirin induced asthma.
    Bennett A
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S54-6. PubMed ID: 10992560
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?
    Kowalski ML
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S84-6. PubMed ID: 10992569
    [No Abstract]   [Full Text] [Related]  

  • 8. [Special features of NSAID intolerance in children].
    Porto Arceo JA
    Allergol Immunopathol (Madr); 2003; 31(3):109-25. PubMed ID: 12783761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aspirin-induced asthma (AIA)].
    Sakakibara H; Yoneda Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():114-9. PubMed ID: 15954335
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of aspirin sensitivity.
    Picado C
    Curr Allergy Asthma Rep; 2006 May; 6(3):198-202. PubMed ID: 16579869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new insight into aspirin-induced asthma.
    Jawien J
    Eur J Clin Invest; 2002 Feb; 32(2):134-8. PubMed ID: 11895461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma.
    Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP
    J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 14. Dual inhibition of cyclo-oxygenases and 5-lipoxygenase: a novel therapeutic approach to inflammation?
    Naveau B
    Joint Bone Spine; 2005 May; 72(3):199-201. PubMed ID: 15850989
    [No Abstract]   [Full Text] [Related]  

  • 15. The broken balance in aspirin hypersensitivity.
    Szczeklik A; Sanak M
    Eur J Pharmacol; 2006 Mar; 533(1-3):145-55. PubMed ID: 16457808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease.
    Crofford LJ
    Arthritis Res Ther; 2003; 5(1):25-7. PubMed ID: 12716444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and NSAID sensitivity.
    Stevenson DD
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of anti-inflammatory analgesics in the patient with cardiovascular disease: what a pain.
    Steinhubl SR
    J Am Coll Cardiol; 2005 Apr; 45(8):1302-3. PubMed ID: 15837266
    [No Abstract]   [Full Text] [Related]  

  • 19. The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding.
    Konstantinopoulos PA; Lehmann DF
    J Clin Pharmacol; 2005 Jul; 45(7):742-50. PubMed ID: 15951464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F; Harrell K; Fischer R
    South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.